Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.64 |
| ▸ | RAB9A | P51151 | 5/20 | 0.64 |
| ▸ | MAPT | P10636 | 5/20 | 0.62 |
| ▸ | MEN1 | O00255 | 3/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.62 |
| ▸ | NPC1 | O15118 | 3/20 | 0.62 |
| ▸ | LMNA | P02545 | 2/20 | 0.59 |
| ▸ | HTT | P42858 | 2/20 | 0.59 |
| ▸ | HPGD | P15428 | 2/20 | 0.58 |
| ▸ | TP53 | P04637 | 1/20 | 0.57 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.57 |
| ▸ | PKM | P14618 | 2/20 | 0.56 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.56 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.56 |
| ▸ | RELA | Q04206 | 1/20 | 0.56 |
| ▸ | GAA | P10253 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15333643 | 0.85 | SMN1; SMN2 (0.67) | ALDH1A1SMN1; SMN2RAB9AMAPTMEN1 | |
| SCHEMBL4935349 | 0.84 | NPC1 (0.74) | ALDH1A1SMN1; SMN2RAB9AMAPTMEN1 | |
| SCHEMBL15332586 | 0.83 | SMN1; SMN2 (0.67) | ALDH1A1SMN1; SMN2RAB9AMAPTMEN1 | |
| SCHEMBL13372593 | 0.81 | ALDH1A1 (0.49) | ALDH1A1SMN1; SMN2RAB9AMAPTMEN1 | |
| SCHEMBL30786728 | 0.80 | KMT2A (0.75) | ALDH1A1SMN1; SMN2RAB9AMAPTMEN1 | |
| SCHEMBL4141992 | 0.80 | KMT2A (0.75) | ALDH1A1SMN1; SMN2RAB9AMAPTMEN1 | |
| SCHEMBL3308492 | 0.80 | KDM4E (0.58) | ALDH1A1SMN1; SMN2RAB9AMAPTMEN1 | |
| SCHEMBL11146966 | 0.79 | TOP1 (0.60) | ALDH1A1SMN1; SMN2RAB9AMAPTMEN1 | |
| SCHEMBL29627549 | 0.79 | KMT2A (0.73) | ALDH1A1SMN1; SMN2RAB9AMAPTMEN1 | |
| SCHEMBL21870128 | 0.78 | RAB9A (0.59) | ALDH1A1SMN1; SMN2RAB9AMAPTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8618285-B2 | Triazole derivatives | MERCK PATENT GMBH (DE) | 2013-12-31 | — | — | US | disclosed |
| EP-1853570-B1 | HSP90-INHIBITING TRIAZOLE DERIVATIVES | MERCK PATENT GMBH (DE) | 2012-10-24 | — | — | EP | disclosed |
| US-20080182857-A1 | Triazole Derivatives | MERCK PATENT GMBH (DE) | 2008-07-31 | — | — | US | disclosed |
| CN-101119978-A | HSP90-inhibiting triazole derivatives | MERCK PATENT GMBH (DE) | 2008-02-06 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080182857-A1 | Triazole Derivatives | HSP90AB1, HSP90AA1, HSP90B1 | ALDH1A1 1580/4885SMN1; SMN2 4072/4885RAB9A 1943/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.